OAM
Oberweis Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,440
| Closed | -$243K | – | 211 |
|
|
2019
Q3 | $243K | Sell |
2,440
-1,300
| -35% | -$129K | 0.05% | 179 |
|
|
2019
Q2 | $427K | Sell |
3,740
-40,909
| -92% | -$4.67M | 0.08% | 156 |
|
|
2019
Q1 | $5.61M | Buy |
44,649
+1,420
| +3% | +$179K | 1.13% | 23 |
|
|
2018
Q4 | $5.87M | Buy |
43,229
+7,642
| +21% | +$1.04M | 1.31% | 20 |
|
|
2018
Q3 | $9.77M | Sell |
35,587
-13,540
| -28% | -$3.72M | 1.89% | 8 |
|
|
2018
Q2 | $10.2M | Buy |
49,127
+335
| +0.7% | +$69.4K | 2.56% | 2 |
|
|
2018
Q1 | $8.06M | Sell |
48,792
-10,560
| -18% | -$1.74M | 2.12% | 8 |
|
|
2017
Q4 | $8.13M | Buy |
59,352
+7,850
| +15% | +$1.07M | 1.9% | 11 |
|
|
2017
Q3 | $7.01M | Buy |
51,502
+2,050
| +4% | +$279K | 1.95% | 14 |
|
|
2017
Q2 | $6M | Sell |
49,452
-1,470
| -3% | -$178K | 1.65% | 17 |
|
|
2017
Q1 | $5.39M | Sell |
50,922
-27,000
| -35% | -$2.86M | 1.59% | 24 |
|
|
2016
Q4 | $7.92M | Buy |
77,922
+3,760
| +5% | +$382K | 2.37% | 8 |
|
|
2016
Q3 | $7.57M | Sell |
74,162
-10,280
| -12% | -$1.05M | 2.18% | 11 |
|
|
2016
Q2 | $10.1M | Sell |
84,442
-7,325
| -8% | -$874K | 2.99% | 4 |
|
|
2016
Q1 | $9.83M | Sell |
91,767
-9,360
| -9% | -$1M | 2.84% | 5 |
|
|
2015
Q4 | $11M | Buy |
101,127
+5,760
| +6% | +$624K | 3.08% | 7 |
|
|
2015
Q3 | $8.17M | Buy |
95,367
+2,060
| +2% | +$176K | 2.38% | 13 |
|
|
2015
Q2 | $9.42M | Sell |
93,307
-32,080
| -26% | -$3.24M | 2.49% | 9 |
|
|
2015
Q1 | $9.67M | Sell |
125,387
-37,000
| -23% | -$2.85M | 2.72% | 6 |
|
|
2014
Q4 | $8.64M | Sell |
162,387
-5,950
| -4% | -$317K | 2.58% | 11 |
|
|
2014
Q3 | $7.91M | Sell |
168,337
-8,500
| -5% | -$399K | 2.17% | 14 |
|
|
2014
Q2 | $11M | Sell |
176,837
-36,900
| -17% | -$2.3M | 2.72% | 7 |
|
|
2014
Q1 | $14.4M | Buy |
213,737
+420
| +0.2% | +$28.3K | 3.02% | 6 |
|
|
2013
Q4 | $11.2M | Buy |
213,317
+64,785
| +44% | +$3.41M | 2.72% | 6 |
|
|
2013
Q3 | $6.43M | Buy |
148,532
+134,532
| +961% | +$5.82M | 1.83% | 23 |
|
|
2013
Q2 | $524K | Buy |
+14,000
| New | +$524K | 0.15% | 100 |
|